Get the Stockscreener App
94.15
3.11%
-3.0129
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $94.15, with a volume of 3.98M.
It is down -3.11% in the last 24 hours and down -12.41% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$97.16
Open:
$96.29
24h Volume:
3.98M
Relative Volume:
0.50
Market Cap:
$120.49B
Revenue:
$407.94B
Net Income/Loss:
$2.90B
P/E Ratio:
41.35
EPS:
2.2771
Net Cash Flow:
$7.39B
1W Performance:
-1.60%
1M Performance:
-12.41%
6M Performance:
+20.38%
1Y Performance:
+37.23%
1-Day Range:
$93.74
$96.50
1-Week Range:
$93.01
$97.51
52-Week Range:
$69.40
$110.68
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
94.20 | 124.26B | 407.94B | 2.90B | 7.39B | 2.2771 |
UNH
Unitedhealth Group Inc
|
394.39 | 360.59B | 450.13B | 14.91B | 23.62B | 15.55 |
ELV
Elevance Health Inc
|
390.76 | 86.82B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
275.37 | 74.66B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
383.51 | 46.72B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-14-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Upgrade | UBS | Neutral → Buy |
| Aug-14-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
CVS Health Corp Stock (CVS) Moved Down by 3.46% on Aug 17: A Full Analysis - TradingKey
CVS Health: Mental Health Can Shape Heart Health Outcomes - ACCESS Newswire
CVS' Q2 EPS Gains From Improved Health Care Benefits Profitability - Zacks Investment Research
AMG National Trust Bank Makes New $5.84 Million Investment in CVS Health Corporation $CVS - MarketBeat
HBK Sorce Advisory LLC Invests $2.26 Million in CVS Health Corporation $CVS - MarketBeat
OneDigital Investment Advisors LLC Makes New Investment in CVS Health Corporation $CVS - MarketBeat
Plato Investment Management Ltd Makes New Investment in CVS Health Corporation $CVS - MarketBeat
Simplicity Wealth LLC Buys Shares of 38,054 CVS Health Corporation $CVS - MarketBeat
Nippon Life Global Investors Americas Inc. Invests $35.95 Million in CVS Health Corporation $CVS - MarketBeat
Global Retirement Partners LLC Acquires New Stake in CVS Health Corporation $CVS - MarketBeat
Spotting Winners: AMN Healthcare Services (NYSE:AMN) And Healthcare Providers & Services Stocks In Q2 - Yahoo Finance
Bernie Sanders Says 'Our Current Healthcare System Is Broken,' Demands Medicare for All as 64% Back Unive - Benzinga
CVS Health Corporation (NYSE:CVS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Orca Investment Management LLC Invests $3.60 Million in CVS Health Corporation $CVS - MarketBeat
CVS Health (NYSE:CVS) stock in focus after raised guidance and weight-management push - Kalkine Media
Oppenheimer Asset Management Inc. Invests $49.62 Million in CVS Health Corporation $CVS - MarketBeat
Larry Robbins's Top Q2 2026 Move: Trimming CVS Health Corp at a -6.08% Portfolio Impact - Yahoo Finance
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
CVS Looks 22.9% Overvalued on GF Value™ as Dividend Sustainabili - GuruFocus
Promising Healthcare Stocks To Add to Your WatchlistAugust 14th - MarketBeat
How CVS Is Building on Its Consumer-Health Care Technology Push - Zacks Investment Research
CVS Health: New Study From CVS Caremark and Employee Benefit News Shows How Employers Rely on Their Pharmacy Benefit Manager To Create Sustainable Pharmacy Solutions - FinanzNachrichten.de
Can CVS Sustain Its 2026 Recovery After Raising Earnings Guidance? - Yahoo Finance
Mark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFs - TradingView
Developer plans drive-thru coffee chain and bank on former CVS site in Pinellas Park - The Business Journals
CVS Health (CVS) Rolls Out New PBM Tools As Employer Trust Grows - Yahoo Finance
The Top 5 Analyst Questions From CVS Health’s Q2 Earnings Call - Yahoo Finance
CVS Health Stock's Next Leg Sits In Aetna's Unfinished Margin Repair - Yahoo Finance
Dodge & Cox (CVS: CVS) reports 50M-share, 3.9% ownership stake in CVS Health - Stock Titan
CVS Health Enhances Its Direct-to-Consumer Weight Management Offerings To Improve Access, Affordability, Care and Support for GLP-1 Medications - marketscreener.com
CVS Health (CVS) Stock Trades Below Fair Value After A 48% Gain - simplywall.st
Employer Survey Signals Coming Shakeup in PBM Market Dynamics - Bloomberg Law News
Invesco Comstock Contrarian Equity ETF's CVS Health Corp(CVS) Holding History - GuruFocus
CVS Maintains Overweight Rating by JP Morgan -- Price Target Rai - GuruFocus
JPMorgan Chase & Co. Issues Positive Forecast for CVS Health (NYSE:CVS) Stock Price - MarketBeat
CVS Caremark study shows employers rely on PBM expertise - CVS Health
CVS Caremark Survey: 80% of Employers Limit or Consider GLP-1 Limits - Stock Titan
Wedge Capital Management L L P NC Has $31.23 Million Position in CVS Health Corporation $CVS - MarketBeat
E. Ohman J or Asset Management AB Decreases Holdings in CVS Health Corporation $CVS - MarketBeat
Boston Partners Global Equity Fund's CVS Health Corp(CVS) Holding History - GuruFocus
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
CVS Health Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
News by ACCESS Newswire on TradingView, 2026-08-11 - TradingView
Handelsbanken Fonder AB Buys 496,124 Shares of CVS Health Corporation $CVS - MarketBeat
Elizabeth Warren Says UnitedHealth, CVS Have Too Much Control Over US Healthcare—Now She Wants to Break Up the Vertical Integration - Yahoo Finance
CVS Health: I Wanted A Beat And Raise, I Got It, And I'm Still At 'Hold' (NYSE:CVS) - Seeking Alpha
Elizabeth Warren Vows to Break the Monopoly of UnitedHealth Group, CVS Health and Cigna: 'I Have a Bill t - Benzinga
Vertrix Wealth Management LLC Invests $3.79 Million in CVS Health Corporation $CVS - MarketBeat
NewEdge Advisors LLC Grows Stake in CVS Health Corporation $CVS - MarketBeat
Oliver Luxxe Assets LLC Boosts Holdings in CVS Health Corporation $CVS - MarketBeat
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):